Electromedical Technologies, Inc (EMED) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US28540Q1004
Electromedical Technologies, Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 588,365.00 USD | 41,195.00 USD |
| Gross profit | 381,201.00 USD | -62,178.00 USD |
| Operating income | -1.06 m USD | -1.02 m USD |
| Net income | -1.29 m USD | -1.44 m USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Electromedical Technologies, Inc
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. The company offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. It also develops WellnessPro POD, a compact clinical-grade wearable device for pain management; and Wellness ION Pen, an interferential cold laser used to deliver targeted frequency stimulation to improve circulation and tissue healing, and reduce inflammation and pain. The company serves chiropractors, physiotherapists, pain management doctors and clinicians, natural medicine doctors, sports medicine doctors, and athletic trainers. Electromedical Technologies, Inc. was founded in 2002 and is headquartered in Scottsdale, Arizona.
More stocks
- Petros Pharmaceuticals, Inc. (PTPI)
- Emo Capital Corp. (NUVI)
- BIOREGENX, INC. (BRGX)
- Bubblr Inc. (BBLR)
- ProPhase Labs, Inc. (PRPH)
- SPLASH BEVERAGE GROUP, INC. (EDVA)
- PINEAPPLE EXPRESS CANNABIS Co (PNXP)
- Zoomcar Holdings, Inc. (ZCAR)
- New Momentum Corp. (NNAX)
- 3DX Industries, Inc. (DDDX)
- Data443 Risk Mitigation, Inc. (ATDS)
- Genprex, Inc. (GNPX)
Not investment advice. All data without warranty, price as of 17.11.2026. Details in the risk notice.